149 related articles for article (PubMed ID: 33045317)
1. LINC00922 regulates epithelial-mesenchymal transition, invasive and migratory capacities in breast cancer through promoting NKD2 methylation.
Wang Y; Dong T; Wang P; Li S; Wu G; Zhou J; Wang Z
Cell Signal; 2021 Jan; 77():109808. PubMed ID: 33045317
[TBL] [Abstract][Full Text] [Related]
2. Down-regulated expression of LINC00518 prevents epithelial cell growth and metastasis in breast cancer through the inhibition of CDX2 methylation and the Wnt signaling pathway.
Wang HB; Wei H; Wang JS; Li L; Chen AY; Li ZG
Biochim Biophys Acta Mol Basis Dis; 2019 Mar; 1865(3):708-723. PubMed ID: 30611858
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA BANCR indicates poor prognosis for breast cancer and promotes cell proliferation and invasion.
Lou KX; Li ZH; Wang P; Liu Z; Chen Y; Wang XL; Cui HX
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1358-1365. PubMed ID: 29565494
[TBL] [Abstract][Full Text] [Related]
4. Silencing NKD2 by Promoter Region Hypermethylation Promotes Esophageal Cancer Progression by Activating Wnt Signaling.
Cao B; Yang W; Jin Y; Zhang M; He T; Zhan Q; Herman JG; Zhong G; Guo M
J Thorac Oncol; 2016 Nov; 11(11):1912-1926. PubMed ID: 27374455
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic silencing of NKD2, a major component of Wnt signaling, promotes breast cancer growth.
Dong Y; Cao B; Zhang M; Han W; Herman JG; Fuks F; Zhao Y; Guo M
Oncotarget; 2015 Sep; 6(26):22126-38. PubMed ID: 26124080
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA LINC01133 silencing exerts antioncogenic effect in pancreatic cancer through the methylation of DKK1 promoter and the activation of Wnt signaling pathway.
Weng YC; Ma J; Zhang J; Wang JC
Cancer Biol Ther; 2019; 20(3):368-380. PubMed ID: 30580676
[TBL] [Abstract][Full Text] [Related]
7. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.
Wu H; Li J; Guo E; Luo S; Wang G
Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800
[TBL] [Abstract][Full Text] [Related]
8. Livin promotes progression of breast cancer through induction of epithelial-mesenchymal transition and activation of AKT signaling.
Li F; Yin X; Luo X; Li HY; Su X; Wang XY; Chen L; Zheng K; Ren GS
Cell Signal; 2013 Jun; 25(6):1413-22. PubMed ID: 23524337
[TBL] [Abstract][Full Text] [Related]
9. Secreted Frizzled Related Protein 2 Modulates Epithelial-Mesenchymal Transition and Stemness via Wnt/β-Catenin Signaling in Choriocarcinoma.
Zeng X; Zhang Y; Xu H; Zhang T; Xue Y; An R
Cell Physiol Biochem; 2018; 50(5):1815-1831. PubMed ID: 30396168
[TBL] [Abstract][Full Text] [Related]
10. LINC00922 promotes the proliferation, migration, invasion and EMT process of liver cancer cells by regulating miR-424-5p/ARK5.
Ye Z; He Q; Wang Q; Lin Y; Cen K; Chen X
Mol Cell Biochem; 2021 Oct; 476(10):3757-3769. PubMed ID: 34097192
[TBL] [Abstract][Full Text] [Related]
11. The long noncoding RNA HOTTIP promotes breast cancer cell migration, invasiveness, and epithelial-mesenchymal transition via the Wnt-β-catenin signaling pathway.
Han S; Jin X; Liu Z; Xing F; Han Y; Yu X; He G; Qiu F
Biochem Cell Biol; 2019 Oct; 97(5):655-664. PubMed ID: 30676763
[TBL] [Abstract][Full Text] [Related]
12. Long Noncoding RNA LINC01006 Facilitates Cell Proliferation, Migration, and Epithelial-Mesenchymal Transition in Lung Adenocarcinoma via Targeting the MicroRNA 129-2-3p/CTNNB1 Axis and Activating Wnt/β-Catenin Signaling Pathway.
Zhang Y; Liu H; Zhang Q; Zhang Z
Mol Cell Biol; 2021 May; 41(6):e0038020. PubMed ID: 33753463
[TBL] [Abstract][Full Text] [Related]
13. LincK contributes to breast tumorigenesis by promoting proliferation and epithelial-to-mesenchymal transition.
Li J; Hao Y; Mao W; Xue X; Xu P; Liu L; Yuan J; Zhang D; Li N; Chen H; Zhao L; Sun Z; Luo J; Chen R; Zhao RC
J Hematol Oncol; 2019 Feb; 12(1):19. PubMed ID: 30795783
[TBL] [Abstract][Full Text] [Related]
14. LINC00922 Accelerates the Proliferation, Migration and Invasion of Lung Cancer Via the miRNA-204/CXCR4 Axis.
Liang T; Wang B; Li J; Liu Y
Med Sci Monit; 2019 Jul; 25():5075-5086. PubMed ID: 31287095
[TBL] [Abstract][Full Text] [Related]
15. Eugenol modulates genomic methylation and inactivates breast cancer-associated fibroblasts through E2F1-dependent downregulation of DNMT1/DNMT3A.
Al-Kharashi LA; Bakheet T; AlHarbi WA; Al-Moghrabi N; Aboussekhra A
Mol Carcinog; 2021 Nov; 60(11):784-795. PubMed ID: 34473867
[TBL] [Abstract][Full Text] [Related]
16. Silence of lncRNA MIAT-mediated inhibition of DLG3 promoter methylation suppresses breast cancer progression via the Hippo signaling pathway.
Li D; Hu X; Yu S; Deng S; Yan M; Sun F; Song J; Tang L
Cell Signal; 2020 Sep; 73():109697. PubMed ID: 32593652
[TBL] [Abstract][Full Text] [Related]
17. DACT1, an antagonist to Wnt/β-catenin signaling, suppresses tumor cell growth and is frequently silenced in breast cancer.
Yin X; Xiang T; Li L; Su X; Shu X; Luo X; Huang J; Yuan Y; Peng W; Oberst M; Kelly K; Ren G; Tao Q
Breast Cancer Res; 2013 Mar; 15(2):R23. PubMed ID: 23497530
[TBL] [Abstract][Full Text] [Related]
18. The long non-coding RNA DANCR regulates the inflammatory phenotype of breast cancer cells and promotes breast cancer progression via EZH2-dependent suppression of SOCS3 transcription.
Zhang KJ; Tan XL; Guo L
Mol Oncol; 2020 Feb; 14(2):309-328. PubMed ID: 31860165
[TBL] [Abstract][Full Text] [Related]
19. The EZH2- H3K27me3-DNMT1 complex orchestrates epigenetic silencing of the wwc1 gene, a Hippo/YAP pathway upstream effector, in breast cancer epithelial cells.
Liu X; Li C; Zhang R; Xiao W; Niu X; Ye X; Li Z; Guo Y; Tan J; Li Y
Cell Signal; 2018 Nov; 51():243-256. PubMed ID: 30121333
[TBL] [Abstract][Full Text] [Related]
20. Downregulated long noncoding RNA LINC00313 inhibits the epithelial-mesenchymal transition, invasion, and migration of thyroid cancer cells through inhibiting the methylation of ALX4.
Zhao X; Hu X
J Cell Physiol; 2019 Nov; 234(11):20992-21004. PubMed ID: 31093972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]